TrademarkDir
TAVANTA
DEAD

Serial Number

90845441

Owner

Tavanta Therapeutics, Inc.

Attorney

C. Brandon Browning

Filing Date

Jul 23, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TAVANTA Trademark

Serial Number: 90845441

TAVANTA is a trademark filed by Tavanta Therapeutics, Inc. on July 23, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Tavanta Therapeutics, Inc. (5 trademarks)

Suite 650
Radnor, PA 19087

Entity Type: 03

Trademark Details

Filing Date

July 23, 2021

Registration Date

Not Registered

Published for Opposition

March 7, 2023

Goods & Services

Housemark for a full line of prescription pharmaceuticals for the treatment of cancer, anal fissures, cystic fibrosis; pharmaceuticals for treatment of cancer, and cystic fibrosis; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, cystic fibrosis, and anal fissures

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 25, 2025 MAB6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 25, 2025 EXRA
CORRECTED NOA E-MAILED
Nov 24, 2025 NOAC
ABANDONMENT - NO USE STATEMENT FILED
Nov 24, 2025 ABN6
SOU EXTENSION 4 GRANTED
Nov 24, 2025 EX4G
DIVISIONAL PROCESSING COMPLETE
Nov 24, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 17, 2025 AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 30, 2025 AITU
SOU EXTENSION 4 FILED
May 2, 2025 EXT4
DIVISIONAL REQUEST RECEIVED
May 2, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
May 2, 2025 ERTD
SOU TEAS EXTENSION RECEIVED
May 2, 2025 EEXT
SOU EXTENSION 3 GRANTED
Nov 5, 2024 EX3G
SOU EXTENSION 3 FILED
Nov 5, 2024 EXT3
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 4, 2024 EXRA
SOU TEAS EXTENSION RECEIVED
Nov 4, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2024 EXRA
SOU EXTENSION 2 GRANTED
May 2, 2024 EX2G
SOU EXTENSION 2 FILED
May 2, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 2, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 4, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 2, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 2, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 2, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 2, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 7, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2023 CRFA
ASSIGNED TO LIE
Jan 30, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 29, 2022 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 27, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 27, 2022 GNSL
SUSPENSION LETTER WRITTEN
Oct 27, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 18, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 18, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 18, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 18, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 18, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2021 NWOS
NEW APPLICATION ENTERED
Jul 27, 2021 NWAP

Related Trademarks

More from this Owner

PULMEVA

PULMEVA

PULMEVA

PULMEVA

TAVANTA

TAVANTA

TAVANTA

TAVANTA

TAVANTA

TAVANTA

TAVANTA THERAPEUTICS

TAVANTA THERAPEUTICS